Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Deanol in tardive dyskinesia: A preliminary report

  • 15 Accesses

  • 27 Citations

Abstract

Deanol, a CNS stimulant and putative precursor of choline, has been given to 10 subjects with tardive dyskinesia. All subjects showed relief of symptoms of TD, possibly through enhancing CNS cholinergic mechanisms.

This is a preview of subscription content, log in to check access.

References

  1. Ambani, L. M., Van Woert, M. H., Bowers, M. B.: Physostigmine effects on phenothiazine-induced extrapyramidal reactions. Arch. Neurol. (Chic.) 29, 444–446 (1973)

  2. Fann, W. E., Davis, J. M., Janowsky, D. S.: Tardive dyskinesia: Findings in two mental hospital populations. Dis. Nerv. Syst. 33, 182–186 (1972a)

  3. Fann, W. E., Lake, C. R., Gerber, C. J., McKenzie, G. M.: Cholinergic suppression of tardive dyskinesia. Psychopharmacologia (Berl.) 37, 101–116 (1972b)

  4. Fann, W. E., Davis, J. M., Wilson, I. C.: Methylphenidate in tardive dyskinesia. Amer. J. Psychiat. 130, 922–924 (1973)

  5. Klawans, H. L., Jr.: The pharmacology of tardive dyskinesia. Amer. J. Psychiat. 130, 82–86 (1973)

  6. Pfeiffer, C. C., Groth, D. P., Bain, J. A.: Choline vs. dimethylaminoethanol (deanol) as possible precursors of cerebral acetylcholine. In: Biological Psychiatry, J. H. Masserman, ed., p. 259. New York: Grune & Stratton, Inc. 1959

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Fann, W.E., Sullivan, J.L., Miller, R.D. et al. Deanol in tardive dyskinesia: A preliminary report. Psychopharmacologia 42, 135–137 (1975). https://doi.org/10.1007/BF00429543

Download citation

Key words

  • Movement Disorders
  • Dyskinesia
  • Acetylcholine
  • Dopamine